Emily Kaiser Maharjan

Aflibercept-jbvf and aflibercept-yszy are the first interchangeable biosimilars to aflibercept 2 mg that have been approved in the US.

Rafieetary emphasizes the importance of follow-up plans and consistent support to prevent patients from dropping out of treatment, which can negatively impact their prognosis.

Nick Bruns, OD, FAAO, talks refractive surgery, from premium IOL options for patients with cataracts to EVO ICL for patients seeking elective corrective surgery.

As part of the sports and performance vision section of the AOA, Vittorio Mena, OD, MS, shares information on how to bolster athletes' performance through enhanced vision care.

IKA Keratoconus Symposium and Controversies in Modern Eye Care shone brightly in May.

IKA Keratoconus Symposium and Controversies in Modern Eye Care shone brightly in May

Jessica Vaidya, OD, chose EVO ICL to correct her myopia and she shares her experience of being the patient with host Miriam Korik, OD. Dr Vaidya talks about her recovery experience, what the procedure felt like, and suggestions for eye care providers when discussion vision corrective surgery options with patients.

Cochair Kelly K. Nichols, OD, PhD, MPH, FAAO, highlights her passion for dry eye research and the vital collaboration between ophthalmology and optometry at EyeCon.

Meeting attendees take courses on and engage in discourse on the field’s latest challenges.

It's time for back-to-school eye exams, and host Miriam Korik, OD, teams up with Eyes Up host Damaris Raymondi, OD, FAAO, to chat about how to handle pediatric eye exams efficiently, thoroughly, and confidently.